Back to top

Image: Bigstock

Has MEDIFAST INC (MED) Outpaced Other Consumer Staples Stocks This Year?

Read MoreHide Full Article

For those looking to find strong Consumer Staples stocks, it is prudent to search for companies in the group that are outperforming their peers. MEDIFAST INC (MED - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? A quick glance at the company's year-to-date performance in comparison to the rest of the Consumer Staples sector should help us answer this question.

MEDIFAST INC is one of 166 individual stocks in the Consumer Staples sector. Collectively, these companies sit at #7 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. MED is currently sporting a Zacks Rank of #1 (Strong Buy).

Within the past quarter, the Zacks Consensus Estimate for MED's full-year earnings has moved 11.45% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Based on the latest available data, MED has gained about 22.09% so far this year. At the same time, Consumer Staples stocks have gained an average of 14.15%. As we can see, MEDIFAST INC is performing better than its sector in the calendar year.

Looking more specifically, MED belongs to the Food - Miscellaneous industry, a group that includes 40 individual stocks and currently sits at #72 in the Zacks Industry Rank. On average, this group has gained an average of 10.34% so far this year, meaning that MED is performing better in terms of year-to-date returns.

Going forward, investors interested in Consumer Staples stocks should continue to pay close attention to MED as it looks to continue its solid performance.


In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


MEDIFAST INC (MED) - free report >>

Published in